• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于肾移植受者新发糖尿病、胰岛素释放及胰岛素敏感性的6年前瞻性研究。

A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients.

作者信息

Hagen Monica, Hjelmesaeth Joran, Jenssen Trond, Morkrid Lars, Hartmann Anders

机构信息

Department of Medicine, Section of Nephrology, Rikshospitalet, 0027 Oslo, Norway.

出版信息

Nephrol Dial Transplant. 2003 Oct;18(10):2154-9. doi: 10.1093/ndt/gfg338.

DOI:10.1093/ndt/gfg338
PMID:13679495
Abstract

BACKGROUND

It is well known that both insulin resistance and insulin deficiency are involved in the pathogenesis of post-transplant diabetes mellitus (PTDM), but the relative importance of the two different mechanisms is still under debate. The present prospective longitudinal study was performed over 6 years to investigate the impact of impaired insulin secretion (ISec) and insulin sensitivity (IS) in the development of PTDM in renal transplant recipients.

METHODS

A total of 95 non-diabetic patients underwent a 75 g oral glucose tolerance test (OGTT) 10 weeks post-transplant. Six years later, 63 of these recipients were re-examined, the majority (n = 58) with an OGTT. Fasting, 1- and 2-h insulin and glucose levels were measured and used to estimate the insulin secretory response and IS both at baseline and at follow-up.

RESULTS

The proportion of recipients with normal glucose tolerance (NGT) rose from 46% (baseline) to 65% (follow-up) (P = 0.008), and median fasting and 2-h serum glucose were reduced by 0.7 mmol/l (P < 0.001) and 1.3 mmol/l (P = 0.039), respectively. The recipients with PTDM at follow-up had a significant decline in the estimated median first and second phase ISec (-58 and -47%, respectively, P = 0.005 for both). The patients who normalized their glucose tolerance from PTDM or IGT at baseline to NGT at follow-up increased their IS significantly (68%, P = 0.002) without significant alterations in ISec.

CONCLUSIONS

Impaired ISec seems to be the dominant mechanism in the development of PTDM after renal transplantation. In contrast, normalization of glucose intolerance is associated with improved IS.

摘要

背景

众所周知,胰岛素抵抗和胰岛素缺乏均参与移植后糖尿病(PTDM)的发病机制,但这两种不同机制的相对重要性仍存在争议。本前瞻性纵向研究历时6年,旨在调查胰岛素分泌受损(ISec)和胰岛素敏感性(IS)对肾移植受者发生PTDM的影响。

方法

95例非糖尿病患者在移植后10周接受了75克口服葡萄糖耐量试验(OGTT)。6年后,对其中63例受者进行了复查,大多数(n = 58)进行了OGTT。测量空腹、1小时和2小时的胰岛素和葡萄糖水平,并用于评估基线和随访时的胰岛素分泌反应和IS。

结果

葡萄糖耐量正常(NGT)的受者比例从46%(基线)升至65%(随访)(P = 0.008),空腹和2小时血清葡萄糖中位数分别降低了0.7 mmol/l(P < 0.001)和1.3 mmol/l(P = 0.039)。随访时发生PTDM的受者估计的第一和第二阶段ISec中位数显著下降(分别为-58%和-47%,两者P = 0.005)。那些从基线时的PTDM或糖耐量受损(IGT)转变为随访时NGT的患者,其IS显著增加(68%,P = 0.002),而ISec无显著变化。

结论

ISec受损似乎是肾移植后发生PTDM的主要机制。相反,糖耐量异常的正常化与IS改善有关。

相似文献

1
A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients.一项关于肾移植受者新发糖尿病、胰岛素释放及胰岛素敏感性的6年前瞻性研究。
Nephrol Dial Transplant. 2003 Oct;18(10):2154-9. doi: 10.1093/ndt/gfg338.
2
The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation.肾移植后胰岛素释放受损和胰岛素抵抗对葡萄糖耐量的影响。
Clin Transplant. 2002 Dec;16(6):389-96. doi: 10.1034/j.1399-0012.2002.02059.x.
3
Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients.肾移植受者移植后糖尿病发病及进展的相关危险因素。
Diabetes Care. 2007 Mar;30(3):609-15. doi: 10.2337/dc06-1277.
4
Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).肾移植受者葡萄糖代谢的早期临床评估:移植后糖尿病(PTDM)的诊断与预测
Nephrol Dial Transplant. 2008 Jun;23(6):2033-42. doi: 10.1093/ndt/gfm875. Epub 2008 Jan 3.
5
[Posttransplantation diabetes mellitus in patients after kidney transplantation - Incidence and risk factors].肾移植术后患者的移植后糖尿病——发病率及危险因素
Dtsch Med Wochenschr. 2016 Sep;141(19):e173-82. doi: 10.1055/s-0042-109448. Epub 2016 Sep 19.
6
Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study.移植后 1 年内胰岛素分泌和胰岛素抵抗轨迹:一项多中心前瞻性队列研究。
Endocrinol Metab (Seoul). 2020 Dec;35(4):820-829. doi: 10.3803/EnM.2020.743. Epub 2020 Nov 18.
7
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation.西他列汀治疗长期稳定肾移植受者移植后新发糖尿病的短期疗效和安全性
Nephrol Dial Transplant. 2014 Apr;29(4):926-33. doi: 10.1093/ndt/gft536. Epub 2014 Jan 22.
8
Oral Glucose Tolerance Test as a Risk Marker for Developing Post-Transplant Diabetes Mellitus.口服葡萄糖耐量试验作为移植后糖尿病发生的风险标志物
Transplant Proc. 2024 Jun;56(5):1061-1065. doi: 10.1016/j.transproceed.2024.04.021. Epub 2024 May 18.
9
Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients.罗格列酮短期治疗可改善肾移植受者的糖耐量、胰岛素敏感性和内皮功能。
Nephrol Dial Transplant. 2005 Feb;20(2):413-8. doi: 10.1093/ndt/gfh641. Epub 2004 Dec 22.
10
beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus.β细胞功能障碍而非胰岛素抵抗是肾移植后糖尿病发生的主要促成因素。
Transplantation. 2001 May 27;71(10):1417-23. doi: 10.1097/00007890-200105270-00011.

引用本文的文献

1
Exploring the Impact of Diabetes on Kidney Transplant: Patient Outcomes and Management Strategies.探索糖尿病对肾移植的影响:患者预后与管理策略
Cureus. 2025 Mar 19;17(3):e80843. doi: 10.7759/cureus.80843. eCollection 2025 Mar.
2
Bibliometric study and visual analysis of postoperative diabetes mellitus in kidney transplant recipients based on WoSCC database.基于Web of Science核心合集数据库的肾移植受者术后糖尿病的文献计量学研究与可视化分析
Ren Fail. 2025 Dec;47(1):2444383. doi: 10.1080/0886022X.2024.2444383. Epub 2025 Jan 13.
3
New-Onset Diabetes Mellitus after Kidney Transplantation.
肾移植后新发糖尿病
J Clin Med. 2024 Mar 27;13(7):1928. doi: 10.3390/jcm13071928.
4
Glucometabolism in Kidney Transplant Recipients with and without Posttransplant Diabetes: Focus on Beta-Cell Function.有和无移植后糖尿病的肾移植受者的糖代谢:关注β细胞功能
Biomedicines. 2024 Jan 30;12(2):317. doi: 10.3390/biomedicines12020317.
5
Exercise and Prediabetes After Renal Transplantation (EXPRED-I): A Prospective Study.肾移植术后运动与糖尿病前期(EXPRED-I):一项前瞻性研究。
Sports Med Open. 2023 May 18;9(1):32. doi: 10.1186/s40798-023-00574-8.
6
Diabetes technology including automated insulin delivery systems to manage hyperglycemia in a failing pancreatic graft: Case series of people with type 1 diabetes and a pancreas kidney or pancreas-only transplant.糖尿病技术,包括自动胰岛素输送系统,以管理衰竭胰腺移植物中的高血糖:1 型糖尿病患者和胰腺肾或胰腺移植患者的病例系列。
J Diabetes Investig. 2023 Jul;14(7):917-920. doi: 10.1111/jdi.14019. Epub 2023 May 16.
7
Progress of new-onset diabetes after liver and kidney transplantation.肝肾移植术后新发糖尿病的研究进展。
Front Endocrinol (Lausanne). 2023 Feb 8;14:1091843. doi: 10.3389/fendo.2023.1091843. eCollection 2023.
8
New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy.肝移植后新发糖尿病(NODM):终极非致糖尿病性免疫抑制疗法
Cureus. 2022 Mar 29;14(3):e23635. doi: 10.7759/cureus.23635. eCollection 2022 Mar.
9
Diabetes in Kidney Transplantation.肾脏移植中的糖尿病。
Adv Chronic Kidney Dis. 2021 Nov;28(6):596-605. doi: 10.1053/j.ackd.2021.10.004.
10
Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach.预防移植后糖尿病:迈向个性化方法。
J Pers Med. 2022 Jan 15;12(1):116. doi: 10.3390/jpm12010116.